{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T09:50:00Z","timestamp":1720345800925},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T00:00:00Z","timestamp":1399593600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s00108-013-3428-z","type":"journal-article","created":{"date-parts":[[2014,5,7]],"date-time":"2014-05-07T06:05:24Z","timestamp":1399442724000},"page":"663-668","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diastolische Herzinsuffizienz"],"prefix":"10.1007","volume":"55","author":[{"given":"R.","family":"Wachter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,9]]},"reference":[{"key":"3428_CR1","doi-asserted-by":"crossref","unstructured":"Bhatia RS, Tu JV, Lee DS et\u00a0al (2006) Outcome of heart failure with preserved ejection fraction in a population-based study. N\u00a0Engl J Med 355:260\u2013269","DOI":"10.1056\/NEJMoa051530"},{"key":"3428_CR2","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","volume":"J","author":"Cleland","year":"2006","unstructured":"Cleland JG, Tendera M, Adamus J et\u00a0al (2006) The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart\u00a0J 27:2338\u20132345","journal-title":"Eur Heart"},{"key":"3428_CR3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jama.2013.905","volume":"309","author":"Edelmann","year":"2013","unstructured":"Edelmann F, Wachter R, Schmidt AG et\u00a0al (2013) Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial. JAMA 309:781\u2013791","journal-title":"JAMA"},{"key":"3428_CR4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","volume":"J","author":"Flather","year":"2005","unstructured":"Flather MD, Shibata MC, Coats AJ et\u00a0al (2005) Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart\u00a0J 26:215\u2013225","journal-title":"Eur Heart"},{"key":"3428_CR5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.110.983866","volume":"124","author":"Guazzi","year":"2011","unstructured":"Guazzi M, Vicenzi M, Arena R, Guazzi MD (2011) Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study. Circulation 124:164\u2013174","journal-title":"Circulation"},{"key":"3428_CR6","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/01.RES.0000129254.25507.d6","volume":"94","author":"Kass","year":"2004","unstructured":"Kass DA, Bronzwaer JG, Paulus WJ (2004) What mechanisms underlie diastolic dysfunction in heart failure? Circ Res 94:1533\u20131542","journal-title":"Circ Res"},{"key":"3428_CR7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jchf.2012.12.002","volume":"1","author":"Maier","year":"2013","unstructured":"Maier LS, Layug B, Karwatowska-Prokopczuk E et\u00a0al (2013) RAnoLazIne for the treatment of diastolic heart failure in patients with preserved ejection fraction: the RALI-DHF proof-of-concept study. JACC Heart Fail 1:115\u2013122","journal-title":"JACC Heart Fail"},{"key":"3428_CR8","doi-asserted-by":"crossref","unstructured":"Massie BM, Carson PE, McMurray JJ et\u00a0al (2008) Irbesartan in patients with heart failure and preserved ejection fraction. N\u00a0Engl J Med 359:2456\u20132467","DOI":"10.1056\/NEJMoa0805450"},{"key":"3428_CR9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs033","volume":"14","author":"McMurray","year":"2012","unstructured":"McMurray JJ, Adamopoulos S, Anker SD et\u00a0al (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14:803\u2013869","journal-title":"Eur J Heart Fail"},{"key":"3428_CR10","first-page":"1750","volume":"J","author":"Meta-analysis","year":"2012","unstructured":"Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) (2012) The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart\u00a0J 33:1750\u20131757","journal-title":"Eur Heart"},{"key":"3428_CR11","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.pcad.2005.02.010","volume":"47","author":"Owan","year":"2005","unstructured":"Owan TE, Redfield MM (2005) Epidemiology of diastolic heart failure. Prog Cardiovasc Dis 47:320\u2013332","journal-title":"Prog Cardiovasc Dis"},{"key":"3428_CR12","doi-asserted-by":"crossref","unstructured":"Owan TE, Hodge DO, Herges RM et\u00a0al (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N\u00a0Engl J Med 355:251\u2013259","DOI":"10.1056\/NEJMoa052256"},{"key":"3428_CR13","doi-asserted-by":"crossref","unstructured":"Pitt B, Pfeffer MA, Assmann SF et\u00a0al (2014) Spironolactone for heart failure with preserved ejection fraction. N\u00a0Engl J Med 370:1381\u20131392","DOI":"10.1056\/NEJMoa1313731"},{"key":"3428_CR14","doi-asserted-by":"crossref","unstructured":"Redfield MM (2011) Heart failure with normal ejection fraction. In: Braunwald\u2019s heart disease. Saunders, Philadelphia\/PH","DOI":"10.1016\/B978-1-4377-0398-6.00030-5"},{"key":"3428_CR15","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","volume":"309","author":"Redfield","year":"2013","unstructured":"Redfield MM, Chen HH, Borlaug BA et\u00a0al (2013) Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 309:1268\u20131277","journal-title":"JAMA"},{"key":"3428_CR16","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0140-6736(12)61227-6","volume":"380","author":"Solomon","year":"2012","unstructured":"Solomon SD, Zile M, Pieske B et\u00a0al (2012) The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase\u00a02 double-blind randomised controlled trial. Lancet 380:1387\u20131395","journal-title":"Lancet"},{"key":"3428_CR17","doi-asserted-by":"crossref","unstructured":"Sossalla S, Kallmeyer B, Wagner S et\u00a0al (2010) Altered Na(+)-currents in atrial fibrillation: effects of ranolazine on arrhythmias and contractility in human atrial myocardium. J\u00a0Am Coll Cardiol 55:2330\u20132342","DOI":"10.1016\/j.jacc.2009.12.055"},{"key":"3428_CR18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/eurheartj\/ehm554","volume":"J","author":"Tribouilloy","year":"2008","unstructured":"Tribouilloy C, Rusinaru D, Mahjoub H et\u00a0al (2008) Prognosis of heart failure with preserved ejection fraction: a 5-year prospective population-based study. Eur Heart\u00a0J 29:339\u2013347","journal-title":"Eur Heart"},{"key":"3428_CR19","doi-asserted-by":"crossref","unstructured":"Veldhuisen DJ van, Cohen-Solal A, Bohm M et\u00a0al (2009) Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: data from SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). J\u00a0Am Coll Cardiol 53:2150\u20132158","DOI":"10.1016\/j.jacc.2009.02.046"},{"key":"3428_CR20","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1093\/eurheartj\/ehp341","volume":"J","author":"Wachter","year":"2009","unstructured":"Wachter R, Schmidt-Schweda S, Westermann D et\u00a0al (2009) Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure. Eur Heart\u00a0J 30:3027\u20133036","journal-title":"Eur Heart"},{"key":"3428_CR21","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","volume":"362","author":"Yusuf","year":"2003","unstructured":"Yusuf S, Pfeffer MA, Swedberg K et\u00a0al (2003) Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved trial. Lancet 362:777\u2013781","journal-title":"Lancet"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-013-3428-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-013-3428-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-013-3428-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T03:58:09Z","timestamp":1565409489000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-013-3428-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,9]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["3428"],"URL":"https:\/\/doi.org\/10.1007\/s00108-013-3428-z","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,9]]}}}